Skip to main content
Shenhong Wu, MD, Oncology, Stony Brook, NY

Shenhong Wu MD

Oncology•Stony Brook, NY

Associate Professor, Medicine, Stony Brook University SOM

Join to view full profile

  • Nicolls RdSte 1Stony Brook, NY 11794

  • Phone+1 631-444-2540

Join Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 2 invites waiting!
  • Read the latest clinical news, personalized to your specialty.
Join DoximityAlready have an account?

Summary

  • Dr. Shenhong Wu, MD is an oncologist in Stony Brook, New York. He is currently licensed to practice medicine in New York and Connecticut. He is affiliated with Northport Veterans Affairs Medical Center and is an Associate Professor at Stony Brook University SOM.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2004 - 2006
  • Bridgeport Hospital/Yale University
    Bridgeport Hospital/Yale UniversityResidency, Internal Medicine, 2001 - 2004
  • Wenzhou Medical College
    Wenzhou Medical CollegeClass of 1987

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2006 - 2028
  • CT State Medical License
    CT State Medical License 2004 - 2006

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2015-2016
  • CMS Meaningful Use Stage 1 Certification P2 Sentinel, Cerner Corporation, 2015-2016
  • CMS Meaningful Use Stage 1 Certification HealtheLife and PowerChart, Cerner Corporation, 2015-2016

Publications & Presentations

PubMed

Press Mentions

  • Cancer Drug Shows Increased Risk of Death When Used in Combination with Other Therapies
    Cancer Drug Shows Increased Risk of Death When Used in Combination with Other TherapiesJanuary 14th, 2016

Dr. Shenhong Wu, Dr. Shenhong Wu, MD, Dr. S Wu